Big pharma is at a crossroads, as J&J, Merck and others prepare to lose heaps of revenue from blockbuster drugs

by | Jan 28, 2024 | Consumer Products, FEATURED, HEADLINE, Investing, Stocks

Big pharmaceutical companies such as Bristol Myers Squibb, Merck and Johnson & Johnson face a looming threat that will put tens of billions of …

FEATURED

Do we need banks?

I was having a candid chat with a banking friend about life, the world and money, and he asked me a series of questions: How do we change culture to … ​Read More

read more